Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-22-039217

General Counsel and Secretary sold 16,926 shares at an average $29.15 ($493,398)

  • General Counsel and Secretary acquired 16,926 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Meisner Lara General Counsel and Secretary 2022-12-20 Option exercise +600 $23.03 $13,818 600 D
Meisner Lara General Counsel and Secretary 2022-12-20 Sale −600 $28.07 $16,842 0 D
Meisner Lara General Counsel and Secretary 2022-12-21 Option exercise +16,326 $23.03 $375,988 16,326 D
Meisner Lara General Counsel and Secretary 2022-12-21 Sale −16,326 $29.19 $476,556 0 D
Derivatives
Meisner Lara General Counsel and Secretary 2022-12-20 Option exercise · Stock Option (Right to Buy) −600 61,047 D
Meisner Lara General Counsel and Secretary 2022-12-21 Option exercise · Stock Option (Right to Buy) −16,326 44,721 D
Open-market sales · 16,926 sh · avg $29.15 · $493,398
Loading xslF345X03/doc4.xml…